Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Idenix v. Gilead: The enablement and written description limits of a genus claim (Journal of Generic Medicine)

Related Content

Cannabis Marketing Proposed Regulations in New York & Neighboring States (Bloomberg Law)

FTC Proposes a Sweeping Rule That Would Ban Nearly All US Noncompete Agreements

3 Reasons Beauty Cos. Should Consider Pursuing Patents

Recent Court Decisions Shed Light on Enforceability of Electronic Contracts in the U.S.

Chief Judge of Western District of Texas Changes Waco Patent Case Assignment System

Fintiv 2.0: USPTO Director Issues Guidance Softening Risk of Discretionary Denial

U.S. Government Authorizes Transactions Related to Patent Protection in Russia

Federal Circuit Clarifies Standard for Fair and Reasonable Exercise of Jurisdiction Based on Demand Letters

ChIPs San Diego: Practicing IP Law and Balancing Life

Storage Solutions To Be Acquired by Jungheinrich

Goodwin Adds IP Litigator In San Francisco (Law360)

Top 5 IP Considerations for Medtech Companies Transitioning To Data-enabled Product Solutions (MedCity News)

Concert Pharmaceuticals To Be Acquired by Sun Pharmaceutical For $576 Million and Contingent Value Rights

2023 Goodwin CLE Days Program

Goodwin Expands California Litigation Team with Intellectual Property Partner Sharon Smith

Merck and Kelun-Biotech Announce $9.5 Billion ADC Collaboration

Life Sciences

Intellectual Property

Complex Litigation & Dispute Resolution

Litigation